Endocrine responses to chronic androstenedione intake in 30-to 56-year-oldmen

Citation
Ga. Brown et al., Endocrine responses to chronic androstenedione intake in 30-to 56-year-oldmen, J CLIN END, 85(11), 2000, pp. 4074-4080
Citations number
34
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
ISSN journal
0021972X → ACNP
Volume
85
Issue
11
Year of publication
2000
Pages
4074 - 4080
Database
ISI
SICI code
0021-972X(200011)85:11<4074:ERTCAI>2.0.ZU;2-I
Abstract
In young men, chronic ingestion of 100 mg androstenedione (ASD), three time s per day, does not increase serum total testosterone but does increase ser um estrogen and ASD concentrations. We investigated the effects of ASD inge stion in healthy 30- to 56-yr-old men. In a double-blind, randomly assigned manner, subjects consumed 100 mg ASD three times daily (n = 28), or placeb o (n = 27) for 28 days. Serum ASD, dihydrotestosterone (DHT), free and tota l testosterone, estradiol, prostate-specific antigen (PSA), and lipid conce ntrations were measured at week 0 and each week throughout the supplementat ion period. Serum total testosterone and PSA concentrations did not change with supplementation. Elevated serum concentrations of ASD (300%), free tes tosterone (45%), DHT (83%), and estradiol (68%) were observed during weeks 1-4 in ASD (P < 0.05). There was no relationship between age and changes in serum ASD (r(2) = 0.024), free testosterone (r(2) = 0.00), or estradiol (r (2) = 0.029) concentrations with ASD, whereas the serum DHT response to ASD ingestion was related to age (r(2) = 0.244; P < 0.05). Serum concentration s of high-density Lipoprotein cholesterol were decreased by 10% during the supplementation period (P < 0.05). These results suggest that the ingestion of 100 mg ASD, three times per day, does not increase serum total testoste rone or PSA concentrations but does elicit increases in ASD, free testoster one, estradiol, and DHT and decreases serum high-density lipoprotein choles terol concentrations.